ACCC 38th [Virtual] National Oncology Conference On-Demand

Hundreds of attendees came together during #ACCCNOC and experienced two days of inspiring, practical, and collaborative presentations. Throughout the conference ideas were exchanged, common experiences discussed, and attendees were able to walk away with tangible solutions for everyday challenges.

 

Search by Category
Search by Format
Sort By
  • Contains 1 Component(s)

    As a result of market pressures to expand value-based healthcare in oncology, the Association of Community Cancer Centers (ACCC) developed the Alternative Payment Model Coalition (APMC) to gain important insights into how alternative payment models (APMs) impact cancer delivery. The APMC focuses primarily on providing education about APMs and other value-based care programs in cancer care. This three-hour workshop will review how best to prepare for the various APM scenarios which may occur in 2022, as well as how to sustain revenue amidst an uncertain future with federal models. Participants will hear from prominent health policy and regulatory representatives and have the opportunity to raise their questions to national experts.

    As a result of market pressures to expand value-based healthcare in oncology, the Association of Community Cancer Centers (ACCC) developed the Alternative Payment Model Coalition (APMC) to gain important insights into how alternative payment models (APMs) impact cancer delivery. The APMC focuses primarily on providing education about APMs and other value-based care programs in cancer care.

    This three-hour workshop will review how best to prepare for the various APM scenarios which may occur in 2022, as well as how to sustain revenue amidst an uncertain future with federal models. Participants will hear from prominent health policy and regulatory representatives and have the opportunity to raise their questions to national experts.

    Alexandra Chong

    Analyst, Patient Care Models Group

    Center for Medicare & Medicaid Innovation (CMMI), Centers for Medicare & Medicaid Services (CMS)

    Alexandra Chong, PhD, is an analyst for CMMI.  Alexandra is currently the policy lead for the Oncology Care Model (OCM) and is leading the development of a future follow-on value-based oncology model.   OCM is a payment model that seeks to increase coordinated and high quality care of patients receiving chemotherapy through monthly and episode payment incentives.  She has led studies and reviews focused on ensuring that clinicians participating with OCM are engaged in patient-centered care, care coordination, quality measure reporting, and the provision of enhanced services.  Alexandra works closely with clinicians and stakeholders in the oncology community to garner feedback on clinical and methodological aspects of cost effectiveness and quality of care of patients. 

    Valerie Csik, BS, MPH, CPPS (Moderator)

    Director, Quality and Care Transformation Sidney Kimmel Cancer Center at the Thomas Jefferson University Health System

    Valerie Csik, MPH, CPPS is the Director of Quality and Care Transformation for the cancer service line at Thomas Jefferson University Health System. She oversees oncology quality initiatives in the Sidney Kimmel Cancer Center, and her responsibilities include managing the cancer center’s participation in the Centers for Medicare and Medicaid Services (CMS) Oncology Care Model program, as well as aligning various shared savings programs and quality initiatives to improve operations and reduce care variation.  

     Since 2005, Csik has been a dedicated volunteer with the American Cancer Society. She has held various leadership positions, serves as the Chair of the Greater Philadelphia Volunteer Leadership Council, and was the Founding Chair of the Young Professionals of the American Cancer SocietyPhiladelphia Chapter 

    Csik started her career at Thomas Jefferson University and then joined the Patient Safety Organization partnering with healthcare systems around the world to evaluate and improve patient safety culture. Valerie returned to Jefferson as Project Director in the department of medical oncology. Her education includes a bachelor’s degree in Healthcare Administration from the University of Scranton and masters degree in Public Health from Thomas Jefferson University. She is also a graduate of the American Hospital Association (AHA) and National Patient Safety Foundation (NPSF) Comprehensive Patient Safety Leadership Fellowship and is a Certified Professional of Patient Safety. 

    Genevieve Kehoe

    Research Analyst, Patient Care Models Group

    Center for Medicare & Medicaid Innovation (CMMI), Centers for Medicare & Medicaid Services (CMS)

    Genevieve Kehoe is the lead for the design of the RO Model’s pricing methodology. She joined CMMI in 2018 and has worked on all aspects of the RO Model’s episode payment structure, including its pricing adjustments, provider exclusions, reconciliation design, and data collection criteria as well as policy related to the Quality Payment Program. She received her Ph.D. in 2011 with a focus on the development of federal programs.

    Brittany La Couture

    Health Insurance Specialist

    Center for Medicare & Medicaid Innovation (CMMI), Centers for Medicare & Medicaid Services (CMS)

    Brittany is a graduate of Georgetown University Law Center, where she focused her studies on health law and policy. After graduation she spent several years working at think tanks such as the Cato Institute and the American Action Forum before joining CMS as a health insurance specialist. Brittany is now the Quality Payment Program policy lead for Alternative Payment Models and their participants.

     

    Mark Liu, MHA (Moderator)

    Director, Strategic Initiatives

    Mount Sinai Health System

    Mark Liu is the Director of Strategic Initiatives for the oncology service line at the Mount Sinai Health Systeman eight-hospital integrated health system in all five boroughs of New York City. He works closely with senior leadership to develop long-term strategy, while collaborating to drive critical projects to completion. 

    He first joined Mount Sinai as part of a team to facilitate the build of Mount Sinai Health Partners, a new entity advancing population health within the health system. Prior to thisLiu managed ambulatory care operations at Memorial Sloan Kettering Cancer Center across nine different solid and hematologic cancers during his eight-year tenure. 

    He received a Bachelor of Science, double majoring in Integrated Neuroscience and Sociology, from Binghamton University.  Liu was selected as a 2008 fellow for the New York University (NYU) Leadership Initiative and NYU Wagner Fellowship for Emerging Leaders in Public Service. He is currently completing his Master of Healthcare Administration at the Mailman School of Public Health at Columbia University.

    Anne Marie Rainey, MSN, RN, CHC (Moderator)

    Director of Quality and Value-based Care

    Clearview Cancer Institute

    Anne Marie Rainey, RN, MSN, CHC, is the Director of Quality and Value-based Care at Clearview Cancer Institute in Huntsville, Alabama. She has previous experience in government quality reporting as a contractor for the Centers for Medicare Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC)

    After obtaining her Master of Nursing in Clinical Leadership and Administration, Rainey transitioned to the community oncology setting. Her work interests include quality metrics analysis, program implementation, health policy, and advocacy for community oncology.  

  • Contains 1 Component(s)

    Cancer Care’s Path to Recovery from the Global Pandemic

    Cancer Care’s Path to Recovery from the Global Pandemic
    Debra Patt, MD, PhD, MBA, FASCO, Executive Vice President, Public Policy and Strategic Initiatives
    Texas Oncology 

    As healthcare systems navigated how to best keep patients with cancer safe during COVID-19, it resulted in dramatic drops in access to care, including preventative screenings, cancer management visits, and surgeries. Now the impact on disease progression, cancer morbidity, and death rates are beginning to be realized. Learn strategies to increase awareness and ramp up screening efforts in your own community through programs like “Time to Screen,” a nationwide campaign that offers assistance and educational resources to connect patients with appropriate screenings and services.

  • Contains 2 Component(s)

    To reduce ED utilization and exposure to infectious disease, this pilot program identified symptoms that could be appropriately managed in a lower level of care setting—a patient’s home. A mobile integrated health team provided clinical interventions and wellness checks, such as hydration and labs, from the safety of patients’ homes. Throughout 2020, the care team made 652 home visits to 169 patients with cancer.

    Michele Goodman, RN, BSN, MBA, Vice President, Cancer Service Line
    Scott A. Kasper, MS, Vice President & Chief, Albuquerque Ambulance Service
    Presbyterian Healthcare Services 

    To reduce ED utilization and exposure to infectious disease, this pilot program identified symptoms that could be appropriately managed in a lower level of care setting—a patient’s home. A mobile integrated health team provided clinical interventions and wellness checks, such as hydration and labs, from the safety of patients’ homes. Throughout 2020, the care team made 652 home visits to 169 patients with cancer.

    • This session will award .50 continuing education credit for physicians, nurses, and pharmacists.

    • This program session is Approved by the National Association of Social Workers (Approval # 886791045-6518) for .50 continuing education contact hour.

  • Contains 2 Component(s)

    With the understanding that patient education about palliative care is an important component of oncology care, this practice implemented an advanced practice provider-physician model to provide this education. Risk-stratification assessment tools establish baseline metrics related to deficits in the areas of nutrition, psychosocial health, performance and mental status changes, skin breakdown, fall risks, incontinence risk, and treatment tolerance, as well as existing co-morbidities. Providers then use these outcome measurements to make patient-specific, safe treatment decisions about chemotherapy, immunotherapy, surgery, and/or radiation.

    Jia Conway, DNP, CRNP, AOCNP, Nurse Practitioner
    Cancer Care Associates of York

    With the understanding that patient education about palliative care is an important component of oncology care, this practice implemented an advanced practice provider-physician model to provide this education. Risk-stratification assessment tools establish baseline metrics related to deficits in the areas of nutrition, psychosocial health, performance and mental status changes, skin breakdown, fall risks, incontinence risk, and treatment tolerance, as well as existing co-morbidities. Providers then use these outcome measurements to make patient-specific, safe treatment decisions about chemotherapy, immunotherapy, surgery, and/or radiation.

  • Contains 1 Component(s)

    Virtual reality (VR) is uniquely positioned to improve patient understanding of cancer and its treatments. During clinical consultations, radiation oncology personnel use a mobile VR cart to provide 3D patient-specific CT, MRI, and PET-CT imaging to enhance provider and patient interaction, improve patient education, and reduce patient distress. Hear results from a clinical study that captured both quantitative and qualitative data on patient acceptance and perceived usefulness of VR in cancer education and treatment.

    Douglas Holt, MD, Chief Resident, Radiation Oncology
    University of Colorado Cancer Center, UCHealth-Oncology Services

    Virtual reality (VR) is uniquely positioned to improve patient understanding of cancer and its treatments. During clinical consultations, radiation oncology personnel use a mobile VR cart to provide 3D patient-specific CT, MRI, and PET-CT imaging to enhance provider and patient interaction, improve patient education, and reduce patient distress. Hear results from a clinical study that captured both quantitative and qualitative data on patient acceptance and perceived usefulness of VR in cancer education and treatment.

    • This session will award .50 continuing education credit for physicians, nurses, and pharmacists.
  • Contains 2 Component(s)

    This cancer program piloted a remote monitoring program for clinically stable COVID-19 positive patients with cancer. Using equipment provided to them by the cancer program, patients reported vital measurements three times daily. Data was collected on a password-protected patient dashboard and monitored 12 hours a day, 7 days a week by advanced practice providers. APPs and physicians worked in tandem to make clinical determinations on appropriate next steps, documenting provider communications and clinical recommendations in the EHR.

    Nancy Bowles, MHA, RN, OCN, CRNI, NEA-BC, CPC, CHONC, Vice President, Nursing
    Laura Matthews, MBA, MPH, Vice President and Administrator
    Inova Schar Cancer Institute

    This cancer program piloted a remote monitoring program for clinically stable COVID-19 positive patients with cancer. Using equipment provided to them by the cancer program, patients reported vital measurements three times daily. Data was collected on a password-protected patient dashboard and monitored 12 hours a day, 7 days a week by advanced practice providers. APPs and physicians worked in tandem to make clinical determinations on appropriate next steps, documenting provider communications and clinical recommendations in the EHR.

    • This session will award .50 continuing education credit(s) for physicians, nurses, and pharmacists.
  • Contains 2 Component(s)

    The DISCO (DIScussions of COst) app educates patients with cancer about potential treatment-related costs and generates tailored questions to prompt cost-related conversations with providers. In a pilot study, the app significantly improved patients’ self-efficacy for managing treatment costs and interacting with providers while decreasing cost-related distress. Most importantly, 100% of these video-recorded clinic visits included a cost discussion on topics ranging from patient co-pays to transportation concerns.

    Lauren M. Hamel, PhD, Assistant Professor, Department of Oncology
    Lorna Mabunda, Clinical Research Assistant, Behavioral & Field Research Core
    Wayne State University School of Medicine; Karmanos Cancer Institute

    The DISCO (DIScussions of COst) app educates patients with cancer about potential treatment-related costs and generates tailored questions to prompt cost-related conversations with providers. In a pilot study, the app significantly improved patients’ self-efficacy for managing treatment costs and interacting with providers while decreasing cost-related distress. Most importantly, 100% of these video-recorded clinic visits included a cost discussion on topics ranging from patient co-pays to transportation concerns.

  • Contains 2 Component(s)

    After data showed that individuals living in two ZIP codes had a 12% and 15% no-show rate, compared to the average of 2.9% across all ZIP codes, this cancer program implemented a screening tool to initiate transportation discussions with patients before “non-compliance” with treatment became an issue. A pilot program addressed identified patient needs using an online transportation platform. Overall no-show appointments decreased by 48% and no-show incidence from patients living in the two at-risk ZIP codes dropped to 1.2% and 1.3%, respectively.

    Rachel Marquez, MPH, Director of Transportation Services
    Cone Health Cancer Center

    After data showed that individuals living in two ZIP codes had a 12% and 15% no-show rate, compared to the average of 2.9% across all ZIP codes, this cancer program implemented a screening tool to initiate transportation discussions with patients before “non-compliance” with treatment became an issue. A pilot program addressed identified patient needs using an online transportation platform. Overall no-show appointments decreased by 48% and no-show incidence from patients living in the two at-risk ZIP codes dropped to 1.2% and 1.3%, respectively.

  • Contains 2 Component(s)

    Increased use of CT scans in emergency departments leads to higher rates of incidental radiologic findings, including adrenal masses and pulmonary lung nodules. In this “pull” model for follow-up care, ED providers use the EHR to prompt oncology nurse navigators and case managers to contact patients with incidental findings. Prompt follow-up allows for earlier diagnosis and treatment—improving care and the patient experience. From a business perspective, the cancer program realized financial gains through additional visits, procedures, surgeries, radiology scans, and/or labs.

    Nicholas Garland, MS, Senior Project Manager
    Katharine Klar, RN, BSN, Assistant Nurse Manager
    Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center

    Increased use of CT scans in emergency departments leads to higher rates of incidental radiologic findings, including adrenal masses and pulmonary lung nodules. In this “pull” model for follow-up care, ED providers use the EHR to prompt oncology nurse navigators and case managers to contact patients with incidental findings. Prompt follow-up allows for earlier diagnosis and treatment—improving care and the patient experience. From a business perspective, the cancer program realized financial gains through additional visits, procedures, surgeries, radiology scans, and/or labs.

  • Contains 1 Component(s)

    Presented by Abbott

    image

    Katie Robinson, PhD, MPH, RD, LD, CNSC, Medical Science Liaison
    Cory Brunton, MS, BSN, RN, Senior Health Economist Analyst
    Abbott

    Please join us in a presentation and dialogue discussing the prevalence of malnutrition in patients with cancer, the guidelines for the nutrition care of these patients, and the impact of malnutrition on healthcare resource utilization and costs. 

    More Information

    Cory Brunton, MS, BSN, RN

    Senior Health Economist Analyst

    Abbott

    Katie Robinson, PhD, MPH, RD, LD, CNSC

    Medical Science Liaison

    Abbott